Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies ; volume:69 ; number:5 ; day:9 ; month:3 ; year:2020 ; pages:683-687 ; date:5.2020
Cancer immunology immunotherapy ; 69, Heft 5 (9.3.2020), 683-687, 5.2020
- Creator
-
Kerepesi, Csaba
Bakacs, Tibor
Moss, Ralph W.
Slavin, Shimon
Anderson, Colin C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02543-6
- URN
-
urn:nbn:de:101:1-2020070513531601142980
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kerepesi, Csaba
- Bakacs, Tibor
- Moss, Ralph W.
- Slavin, Shimon
- Anderson, Colin C.
- SpringerLink (Online service)
Other Objects (12)
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors